IMP
Process View
regulation of smooth muscle cell proliferation
Any process that modulates the frequency, rate or extent of smooth muscle cell proliferation.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of smooth muscle cell proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.999 | Human Rat | |
| EGFR | epidermal growth factor receptor | 0.999 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.998 | ||
| VEGFA | vascular endothelial growth factor A | 0.996 | Human Rat | |
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.996 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.995 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.994 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.991 | ||
| ESR1 | estrogen receptor 1 | 0.990 | Rat | |
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.986 | Rat | |
| IL8 | interleukin 8 | 0.968 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.939 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.921 | ||
| JAG1 | jagged 1 | 0.910 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.892 | Rat | |
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.889 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.881 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.848 | ||
| JUP | junction plakoglobin | 0.772 | Human | |
| EP300 | E1A binding protein p300 | 0.768 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.763 | Human | |
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.757 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.754 | ||
| NRP1 | neuropilin 1 | 0.751 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.746 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.735 | Human | |
| FN1 | fibronectin 1 | 0.725 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.690 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.689 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.684 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.665 | ||
| TBXA2R | thromboxane A2 receptor | 0.658 | Human | |
| FGFR1 | fibroblast growth factor receptor 1 | 0.645 | ||
| IL1B | interleukin 1, beta | 0.561 | ||
| CREBBP | CREB binding protein | 0.552 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.530 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.520 | ||
| PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) | 0.516 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.495 | ||
| ANG | angiogenin, ribonuclease, RNase A family, 5 | 0.482 | ||
| NOTCH1 | notch 1 | 0.482 | ||
| PGF | placental growth factor | 0.438 | Human | |
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.436 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.396 | ||
| DSG2 | desmoglein 2 | 0.379 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.375 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.371 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.358 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.356 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.355 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.349 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.343 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.331 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.327 | ||
| AR | androgen receptor | 0.319 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.310 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.308 | ||
| FGF10 | fibroblast growth factor 10 | 0.298 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.297 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.295 | Human | |
| INSR | insulin receptor | 0.294 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.279 | ||
| PXN | paxillin | 0.277 | ||
| IL2RB | interleukin 2 receptor, beta | 0.271 | ||
| CD34 | CD34 molecule | 0.245 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.245 | Human | |
| IL23A | interleukin 23, alpha subunit p19 | 0.240 | ||
| RUNX1 | runt-related transcription factor 1 | 0.236 | ||
| FSTL1 | follistatin-like 1 | 0.232 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.217 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.211 | Human | |
| RNASE4 | ribonuclease, RNase A family, 4 | 0.204 | Human | |
| NCOA1 | nuclear receptor coactivator 1 | 0.203 | ||
| FBLN1 | fibulin 1 | 0.202 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.202 | ||
| PGR | progesterone receptor | 0.202 | ||
| FGF7 | fibroblast growth factor 7 | 0.199 | ||
| ENG | endoglin | 0.198 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.194 | Human | |
| SKP1 | S-phase kinase-associated protein 1 | 0.192 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.187 | ||
| S100B | S100 calcium binding protein B | 0.186 | ||
| CRYAB | crystallin, alpha B | 0.176 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.174 | ||
| IFNG | interferon, gamma | 0.173 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.172 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.171 | Human | |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.166 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.164 | ||
| SIRT1 | sirtuin 1 | 0.163 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.158 | Rat | |
| MPO | myeloperoxidase | 0.157 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.156 | Rat | |
| PELI3 | pellino homolog 3 (Drosophila) | 0.153 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.151 | ||
| PRMT2 | protein arginine methyltransferase 2 | 0.148 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.148 | Human | |
| IRS1 | insulin receptor substrate 1 | 0.147 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.146 | Human | |
| COL1A1 | collagen, type I, alpha 1 | 0.142 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.139 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.132 | ||
| THBS1 | thrombospondin 1 | 0.130 | ||
| PSEN1 | presenilin 1 | 0.123 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.123 | ||
| KITLG | KIT ligand | 0.120 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.119 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.117 | ||
| KLF6 | Kruppel-like factor 6 | 0.116 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.115 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.115 | Rat | |
| ICAM1 | intercellular adhesion molecule 1 | 0.114 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.111 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.110 | ||
| DCN | decorin | 0.107 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.107 | Human | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.106 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.105 | ||
| C3 | complement component 3 | 0.103 | ||
| JUN | jun proto-oncogene | 0.099 | Rat | |
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.099 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.098 | ||
| EDN1 | endothelin 1 | 0.098 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.097 | ||
| IDE | insulin-degrading enzyme | 0.095 | ||
| PARVA | parvin, alpha | 0.094 | ||
| KLF5 | Kruppel-like factor 5 (intestinal) | 0.091 | ||
| TCF4 | transcription factor 4 | 0.090 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.089 | Human | |
| CTBP1 | C-terminal binding protein 1 | 0.086 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.085 | ||
| STRN | striatin, calmodulin binding protein | 0.085 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.085 | ||
| ATF5 | activating transcription factor 5 | 0.084 | ||
| IL7R | interleukin 7 receptor | 0.084 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.083 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.082 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.081 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.081 | ||
| PRKCA | protein kinase C, alpha | 0.078 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.077 | ||
| TDGF1 | teratocarcinoma-derived growth factor 1 | 0.077 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.076 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.075 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.075 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.074 | ||
| AP2M1 | adaptor-related protein complex 2, mu 1 subunit | 0.072 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.072 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.071 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.071 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.068 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.068 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.068 | ||
| RARA | retinoic acid receptor, alpha | 0.068 | ||
| DSP | desmoplakin | 0.067 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.066 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.065 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.063 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.062 | Human | |
| ESRRG | estrogen-related receptor gamma | 0.058 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.057 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.056 | ||
| HR | hairless homolog (mouse) | 0.056 | ||
| SELE | selectin E | 0.055 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.054 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.053 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.053 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.052 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.052 | ||
| CTGF | connective tissue growth factor | 0.050 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.050 | ||
| HIC1 | hypermethylated in cancer 1 | 0.049 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.049 | ||
| PDGFC | platelet derived growth factor C | 0.048 | ||
| BMP2 | bone morphogenetic protein 2 | 0.047 | Human | |
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.047 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.047 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.047 | ||
| INO80B | INO80 complex subunit B | 0.047 | ||
| AXL | AXL receptor tyrosine kinase | 0.047 | ||
| MARCO | macrophage receptor with collagenous structure | 0.046 | ||
| VEGFC | vascular endothelial growth factor C | 0.046 | Human | |
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.046 | ||
| AZU1 | azurocidin 1 | 0.045 | Human | |
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.045 | ||
| FTL | ferritin, light polypeptide | 0.043 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.042 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.042 | ||
| IRF7 | interferon regulatory factor 7 | 0.041 | ||
| POLA2 | polymerase (DNA directed), alpha 2 (70kD subunit) | 0.041 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.041 | ||
| NOV | nephroblastoma overexpressed gene | 0.041 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.039 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.039 | ||
| IL6R | interleukin 6 receptor | 0.038 | ||
| RXRA | retinoid X receptor, alpha | 0.036 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.036 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.036 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.035 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.035 | ||
| PLAT | plasminogen activator, tissue | 0.035 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.034 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.033 | ||
| CD83 | CD83 molecule | 0.033 | ||
| CLC | Charcot-Leyden crystal protein | 0.033 | ||
| PRTN3 | proteinase 3 | 0.032 | Human | |
| C2 | complement component 2 | 0.032 | ||
| SSX4 | synovial sarcoma, X breakpoint 4 | 0.031 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.031 | ||
| CH25H | cholesterol 25-hydroxylase | 0.030 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.030 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.030 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.030 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.029 | ||
| PTRF | polymerase I and transcript release factor | 0.029 | ||
| EMD | emerin | 0.028 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.028 | Human | |
| STAB1 | stabilin 1 | 0.028 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.028 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.028 | ||
| BCL2A1 | BCL2-related protein A1 | 0.027 | ||
| EEA1 | early endosome antigen 1 | 0.027 | ||
| MEF2A | myocyte enhancer factor 2A | 0.027 | ||
| EGR1 | early growth response 1 | 0.027 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.026 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.026 | ||
| ITGA6 | integrin, alpha 6 | 0.026 | ||
| FHL2 | four and a half LIM domains 2 | 0.026 | ||
| OMD | osteomodulin | 0.026 | ||
| DARC | Duffy blood group, chemokine receptor | 0.026 | ||
| SP1 | Sp1 transcription factor | 0.026 | ||
| SPP1 | secreted phosphoprotein 1 | 0.026 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.025 | ||
| TNF | tumor necrosis factor | 0.025 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.025 | Human | |
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.025 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.025 | Human | |
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.025 | ||
| INHBA | inhibin, beta A | 0.025 | ||
| IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.025 | Human | |
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.025 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.024 | ||
| SHARPIN | SHANK-associated RH domain interactor | 0.024 | ||
| UBQLN1 | ubiquilin 1 | 0.024 | ||
| E2F1 | E2F transcription factor 1 | 0.024 | ||
| IRS2 | insulin receptor substrate 2 | 0.024 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.024 | ||
| DEFA4 | defensin, alpha 4, corticostatin | 0.023 | ||
| LDLR | low density lipoprotein receptor | 0.023 | ||
| PKP2 | plakophilin 2 | 0.023 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.023 | ||
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.023 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.023 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.023 | ||
| TF | transferrin | 0.023 | ||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.023 | Human | |
| JAK2 | Janus kinase 2 | 0.023 | ||
| SLAMF8 | SLAM family member 8 | 0.022 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.022 | ||
| APC | adenomatous polyposis coli | 0.022 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.022 | Human | |
| MUL1 | mitochondrial E3 ubiquitin protein ligase 1 | 0.022 | ||
| ZNF331 | zinc finger protein 331 | 0.022 | ||
| RNH1 | ribonuclease/angiogenin inhibitor 1 | 0.022 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.022 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.022 | ||
| DLL1 | delta-like 1 (Drosophila) | 0.022 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.021 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.021 | ||
| BMP4 | bone morphogenetic protein 4 | 0.021 | ||
| IRAK1 | interleukin-1 receptor-associated kinase 1 | 0.021 | Rat | |
| PLG | plasminogen | 0.021 | ||
| OSMR | oncostatin M receptor | 0.021 | ||
| PTX3 | pentraxin 3, long | 0.021 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.021 | ||
| MIF4GD | MIF4G domain containing | 0.020 | ||
| GHRL | ghrelin/obestatin prepropeptide | 0.020 | ||
| STC1 | stanniocalcin 1 | 0.020 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.020 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.019 | ||
| GHR | growth hormone receptor | 0.019 | ||
| PFN1 | profilin 1 | 0.019 | ||
| SLAMF7 | SLAM family member 7 | 0.019 | ||
| FOXO1 | forkhead box O1 | 0.019 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.019 | ||
| OLFML3 | olfactomedin-like 3 | 0.018 | ||
| APOE | apolipoprotein E | 0.018 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.018 | ||
| CD163 | CD163 molecule | 0.018 | ||
| GPX3 | glutathione peroxidase 3 (plasma) | 0.018 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.018 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.018 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.018 | ||
| EMP1 | epithelial membrane protein 1 | 0.018 | ||
| SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | 0.018 | ||
| G0S2 | G0/G1switch 2 | 0.018 | ||
| JAK1 | Janus kinase 1 | 0.018 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.018 | ||
| HDAC3 | histone deacetylase 3 | 0.018 | ||
| PARVB | parvin, beta | 0.018 | ||
| CDC6 | cell division cycle 6 homolog (S. cerevisiae) | 0.017 | ||
| RHOB | ras homolog gene family, member B | 0.017 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.017 | ||
| LEF1 | lymphoid enhancer-binding factor 1 | 0.017 | Human | |
| TERF2 | telomeric repeat binding factor 2 | 0.017 | ||
| IL10 | interleukin 10 | 0.017 | ||
| WISP2 | WNT1 inducible signaling pathway protein 2 | 0.017 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.016 | Rat | |
| FZD4 | frizzled homolog 4 (Drosophila) | 0.016 | ||
| CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 | 0.016 | ||
| BPI | bactericidal/permeability-increasing protein | 0.016 | ||
| MS4A3 | membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | 0.016 | ||
| ELANE | elastase, neutrophil expressed | 0.016 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.016 | Human | |
| RUNX3 | runt-related transcription factor 3 | 0.016 | ||
| TMEM176A | transmembrane protein 176A | 0.016 | ||
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.016 | Human | |
| IL11 | interleukin 11 | 0.016 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.016 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.016 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.016 | ||
| IL4R | interleukin 4 receptor | 0.016 | ||
| FXYD1 | FXYD domain containing ion transport regulator 1 | 0.016 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.016 | ||
| UBD | ubiquitin D | 0.015 | ||
| IL32 | interleukin 32 | 0.015 | ||
| PDZD3 | PDZ domain containing 3 | 0.015 | ||
| CD248 | CD248 molecule, endosialin | 0.015 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.015 | ||
| ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.015 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.015 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.015 | ||
| LAT | linker for activation of T cells | 0.015 | ||
| IL21R | interleukin 21 receptor | 0.015 | ||
| CPA3 | carboxypeptidase A3 (mast cell) | 0.015 | ||
| FERMT2 | fermitin family member 2 | 0.015 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.015 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.015 | ||
| AVPR2 | arginine vasopressin receptor 2 | 0.015 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.015 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.015 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.015 | ||
| NOS2 | nitric oxide synthase 2, inducible | 0.014 | ||
| ARRB1 | arrestin, beta 1 | 0.014 | ||
| MYLK2 | myosin light chain kinase 2 | 0.014 | ||
| CTSG | cathepsin G | 0.014 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.014 | ||
| IGFBP1 | insulin-like growth factor binding protein 1 | 0.014 | Human | |
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.014 | ||
| HDAC5 | histone deacetylase 5 | 0.014 | ||
| KRT5 | keratin 5 | 0.014 | ||
| C10orf46 | chromosome 10 open reading frame 46 | 0.014 | ||
| RGS3 | regulator of G-protein signaling 3 | 0.014 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.014 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.014 | ||
| NOTCH3 | notch 3 | 0.014 | Mouse | |
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.014 | Human | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.014 | ||
| SLA | Src-like-adaptor | 0.014 | ||
| HDAC6 | histone deacetylase 6 | 0.014 | ||
| S100P | S100 calcium binding protein P | 0.014 | ||
| MPEG1 | macrophage expressed 1 | 0.014 | ||
| SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.014 | ||
| TLR2 | toll-like receptor 2 | 0.014 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.014 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.013 | ||
| CHORDC1 | cysteine and histidine-rich domain (CHORD) containing 1 | 0.013 | ||
| PTGER4 | prostaglandin E receptor 4 (subtype EP4) | 0.013 | Human | |
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.013 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.013 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.013 | ||
| SRGN | serglycin | 0.013 | ||
| NNMT | nicotinamide N-methyltransferase | 0.013 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.013 | ||
| IL1A | interleukin 1, alpha | 0.013 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.013 | ||
| MAPT | microtubule-associated protein tau | 0.013 | ||
| DPT | dermatopontin | 0.013 | ||
| EREG | epiregulin | 0.013 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.013 | ||
| C14orf43 | chromosome 14 open reading frame 43 | 0.013 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.013 | ||
| FRZB | frizzled-related protein | 0.013 | ||
| CFD | complement factor D (adipsin) | 0.012 | ||
| EFNA1 | ephrin-A1 | 0.012 | ||
| SKIL | SKI-like oncogene | 0.012 | ||
| EFEMP1 | EGF containing fibulin-like extracellular matrix protein 1 | 0.012 | ||
| AXIN1 | axin 1 | 0.012 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.012 | ||
| CSNK1E | casein kinase 1, epsilon | 0.012 | ||
| ANGPT1 | angiopoietin 1 | 0.012 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.012 | ||
| ZFAND5 | zinc finger, AN1-type domain 5 | 0.012 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.012 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.012 | ||
| BTRC | beta-transducin repeat containing | 0.012 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.012 | Human | |
| PKP3 | plakophilin 3 | 0.012 | ||
| CST7 | cystatin F (leukocystatin) | 0.012 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.012 | Human | |
| LEP | leptin | 0.012 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.012 | ||
| PTEN | phosphatase and tensin homolog | 0.012 | ||
| MDK | midkine (neurite growth-promoting factor 2) | 0.012 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.012 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.012 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.012 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.012 | Human | |
| NOTCH4 | notch 4 | 0.012 | ||
| PLEKHA4 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 | 0.012 | ||
| PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.012 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.012 | ||
| PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | 0.011 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.011 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.011 | ||
| CAMP | cathelicidin antimicrobial peptide | 0.011 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.011 | ||
| APP | amyloid beta (A4) precursor protein | 0.011 | ||
| LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0.011 | ||
| LAMB3 | laminin, beta 3 | 0.011 | ||
| ARL4C | ADP-ribosylation factor-like 4C | 0.011 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.011 | ||
| PTK7 | PTK7 protein tyrosine kinase 7 | 0.011 | ||
| ORC2 | origin recognition complex, subunit 2 | 0.011 | ||
| FBXW11 | F-box and WD repeat domain containing 11 | 0.011 | ||
| NKG7 | natural killer cell group 7 sequence | 0.011 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.011 | ||
| ESPN | espin | 0.011 | ||
| VAV3 | vav 3 guanine nucleotide exchange factor | 0.011 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.011 | ||
| PELI1 | pellino homolog 1 (Drosophila) | 0.011 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.011 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.011 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.011 | Human | |
| KRT14 | keratin 14 | 0.011 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.011 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.011 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.011 | ||
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.011 | ||
| MGP | matrix Gla protein | 0.011 | ||
| MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 0.010 | ||
| UNC119 | unc-119 homolog (C. elegans) | 0.010 | ||
| VKORC1 | vitamin K epoxide reductase complex, subunit 1 | 0.010 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.010 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.010 | ||
| COL4A4 | collagen, type IV, alpha 4 | 0.010 | ||
| NFATC4 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 | 0.010 | ||
| SLMAP | sarcolemma associated protein | 0.010 | ||
| FLNA | filamin A, alpha | 0.010 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.010 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.010 | ||
| SERTAD1 | SERTA domain containing 1 | 0.010 | ||
| COASY | CoA synthase | 0.010 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.010 | Rat | |
| GPC3 | glypican 3 | 0.010 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.010 | Rat |